Looking ahead to 2030, our model projects INCY could trade at an average price of $162.86, with a potential range between $122.15 and $203.58. This represents a potential 27.3% return from today's ...

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and ...

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and ...